Endogenex said the study "demonstrates substantial and durable reduction in insulin resistance and improvement in beta cell ...

Aktiia announced today that it raised an oversubscribed $42 million Series B funding round and introduced its new "Hilo" ...

Rhythm Technologies (Nasdaq: IRTC) shares are on the rise on first-quarter results that were mixed compared to the Wall ...

The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...

ElectroCore (Nasdaq:ECOR) announced today that it completed its previously announced acquisition of NeuroMetrix  (Nasdaq:NURO ...

Inquis Medical today announced findings from the AVENTUS trial evaluating the safety and efficacy of its Aventus thrombectomy ...

Baxter EVP and CFO Joel Grade said some tariff mitigation activities are underway while others are being developed.

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

Resmed (NYSE: RMD) announced today that it acquired VirtuOx, a leading independent diagnostic testing facility (IDTF).

Element Science announced today that it received FDA pre-market approval for its Jewel patch wearable cardioverter ...

CEO Jason Hollar said Cardinal Health is "engaging" with the Trump Administration "to try to mitigate impact to patient care.

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.